Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Oncology

Background:

• Liposomes (L) are biocompatible nanovesicles used in drug delivery.
• Stimuli-responsive L offer targeted drug release based on specific triggers.
• Dual- and multi-responsive L provide enhanced precision for cancer therapy.

Purpose of the Study:

• To review recent advancements in stimuli-responsive liposomal nanocarriers for cancer therapy.
• To focus on endogenous stimuli-responsive L, and dual- and multi-responsive L.
• To discuss design strategies, mechanisms, and applications of these smart L.

Main Methods:

• Literature review of nanotechnology advancements in cancer therapy.
• Analysis of stimuli-responsive liposomal nanocarrier design and mechanisms.
• Exploration of applications in targeted drug delivery and controlled release.

Main Results:

• Stimuli-responsive L enhance drug encapsulation and release.
• Dual- and multi-responsive L improve therapeutic precision and reduce toxicity.
• Smart L enable site-specific targeting and controlled drug release.

Conclusions:

• Nanotechnology-based liposomes are revolutionizing cancer therapy.
• Stimuli-responsive, dual-, and multi-responsive L offer significant advantages in efficacy and safety.
• Further research into smart L design and application holds great promise for oncology treatments.